INO has prediction data but was not covered by the substance/hype scanner. Below are the gap-up predictions for this ticker.
INO MISS -4.6%
Prediction Score
0.8
Est. Gap
~20%
Prior Close
$1.21
Pre-Market
$1.13 -6.2%
Patterns Unprocessed Filing Activity
Catalyst Offering Dilution (75% confidence)
AI Analysis

The Unprocessed Filing Activity pattern suggests INO filed significant documentation after hours that the market hasn't fully digested, creating information asymmetry that typically resolves with a gap-up as algorithms and institutional traders process the news overnight. With a 2.1x lift factor and historical 20% average gap for this pattern, the technical setup is compelling despite the low confidence tier. The primary risk is INO's penny stock status at $1.21, making it highly susceptible to manipulation and extreme volatility that can quickly reverse any gap-up momentum, especially given the biotech sector's binary nature around regulatory news. Additionally, the single pattern match leaves little confirmation from other technical indicators. The neutral social sentiment (0.53) with relatively low engagement (30 messages) neither strongly supports nor contradicts the pattern signal, suggesting retail traders haven't yet caught wind of whatever triggered the filing pattern, which could actually be favorable for the gap-up thesis if institutional money moves first.

This prediction missed — the stock opened -4.6%, below the 5% gap target.
Live Market Data
Price
$1.16 -1.69%
Volume
1,113,700
0.7x avg
Market Cap
$95M
52-Week Range
$1.03 — $2.98
Float
81.9M
Short Interest
20.9%
Analyzing... (this may take 10-15 seconds)